Sanofi Says China Sales Grew 47% to $370 Million in Q3

Sanofi reported its China revenues climbed 47% in Q3 to $370 million, a gain of $119 million. About one-third of that rise can be attributed to Sanofi’s acquisition of BMP Sunstone, whose sales were running about $40 million per quarter when the company was still an independent entity. The quarter puts Sanofi at an annual run rate of $1.5 billion for China revenues. More details.... Stock Symbol: (NYSE: SNY)